Table 2.
MYBPC3 c.2149–1G>A |
MYBP3 p.Arg502Trp/Gln |
P value | |||||
Male | Female | Total | Male | Female | Total | ||
N | 10 | 4 | 14 | 12 | 6 | 18 | |
LVEDV (mean±SD, mL) | 188±47 | 144±18 | 175±45 | 195±57 | 178±39 | 190±51 | 0.407 |
LVESV (mean±SD, mL) | 83±26 | 55±18 | 75±27 | 98±33 | 86±53 | 94±39 | 0.128 |
EF (mean±SD, %) | 56±12 | 63±8 | 58±11 | 49±14 | 55±17 | 51±15 | 0.163 |
LV mass (mean±SD, g) | 151±47 | 91±15 | 134±48 | 161±72 | 103±16 | 142±65 | 0.669 |
LV mass index (mean±SD, g per m2) | 78±36 | 50±6 | 65±29 | 84±36 | 53±5 | 77±34 | 0.399 |
Fibrotic mass (mean±SD, g) | 38±49 | 12±7 | 31±43 | 39±42 | 37±26 | 38±36 | 0.620 |
Fibrotic mass index (mean±SD, g per m2) | 27±39 | 7±5 | 18±30 | 20±21 | 22±21 | 21±20 | 0.798 |
% fibrosis (mean±SD, %) | 17±17 | 12±6 | 16±14 | 20±14 | 28±17 | 23±15 | 0.195 |
LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume; EF, ejection fraction.